ENVBVSINDP• 3 Months (Normalized)
ENVB vs INDP (Enveric Biosciences Inc. vs Indaptus Therapeutics Inc.)
Showing Closing Date Range from Jun, 17 to Sep, 15, 2026.
Normalized cumulative comparison anchored at 0.00% baseline to illustrate pure alpha, return divergence, and market momentum.
ENVB Performance $1.46
+12.31%
Enveric Biosciences Inc.
Normalized Baseline0.00%
INDP Performance $3.64
-19.11%
Indaptus Therapeutics Inc.
Normalized Baseline0.00%
Alpha Spread Margin ENVB LEADS
+31.42%
ENVB outperforming by 31.42%
ENVBINDP
Spread Trajectory3 Months (Normalized)
Cumulative Performance Trajectory
Interactive divergence comparison normalized at 0.00% on start date.
ENVB INDP
Comparative Historical Ledger
Daily closing prices, normalized percentages, and relative spread divergence.
Historical Quotes & Breakdown(62 dates)
| Date | ENVB Price | ENVB Gain (%) | INDP Price | INDP Gain (%) | Spread |
|---|---|---|---|---|---|
| Sep 15, 2026 | $1.46 | +12.31% | $3.64 | -19.11% | +31.42% |
| Sep 14, 2026 | $1.48 | +13.85% | $3.14 | -30.22% | +44.07% |
| Sep 11, 2026 | $1.42 | +9.23% | $2.77 | -38.44% | +47.67% |
| Sep 10, 2026 | $1.46 | +12.31% | $2.56 | -43.11% | +55.42% |
| Sep 09, 2026 | $1.46 | +11.92% | $2.08 | -53.78% | +65.70% |
| Sep 08, 2026 | $1.42 | +9.23% | $1.85 | -58.89% | +68.12% |
| Sep 04, 2026 | $1.39 | +6.92% | $1.22 | -72.89% | +79.81% |
| Sep 03, 2026 | $1.44 | +10.77% | $1.16 | -74.22% | +84.99% |
| Sep 02, 2026 | $1.44 | +10.77% | $1.17 | -74.00% | +84.77% |
| Sep 01, 2026 | $1.37 | +5.38% | $1.13 | -74.89% | +80.27% |
| Aug 31, 2026 | $1.37 | +5.38% | $1.15 | -74.56% | +79.94% |
| Aug 28, 2026 | $1.37 | +5.38% | $1.14 | -74.67% | +80.05% |
| Aug 27, 2026 | $1.37 | +5.38% | $1.16 | -74.22% | +79.60% |
| Aug 26, 2026 | $1.37 | +5.38% | $1.14 | -74.67% | +80.05% |
| Aug 25, 2026 | $1.46 | +12.31% | $1.10 | -75.67% | +87.98% |
Page 1 of 5